Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

Clinical trial NCT03602339 · COMPLETED

Trial details

NCT number: NCT03602339
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Magnetic Resonance Imaging

Start date: 2018-11-14
Primary completion: 2020-03-13
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.